出处
《浙江中西医结合杂志》
2007年第1期39-40,共2页
Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
基金
温州市科技局资助课题(No:Y2005A119)
参考文献3
-
1Shinkai K,Akedo H,Mukai M et al.Inhibition of in vitro tumor cell invasion by ginsenoside Rgs.JPN J Cancer Res,1996,87(4):357-362
-
2方全.血管生成素与肿瘤新生血管生成[J].国外医学(生理病理科学与临床分册),2001,21(5):345-347. 被引量:5
-
3郭学良.抗肿瘤血管生成治疗进展[J].复旦学报(医学版),2002,29(1):75-78. 被引量:4
二级参考文献39
-
1Jin RJ, Kwak C, Lee SG, et al. The application of an anti-angiogenic gene( thrombospondin-1 ) in the treatment of human prostate cancer xenografts. Cancer Gene Ther ,2000,7(12): 1537
-
2Zhang Y, Griffith EC,Sage J, et al. Cell cycle inhibition by the antiangiogenic agent TNP-470 is mediated by p53 and p21 WAF1/CIP1.Proc NatlAcad Sci USA,2000,97(12):6427
-
3Aparicio T, Kermorgant S, Dessirer V, et al. Matrix matalloproteinase inhibition prevents cokon caner peritoneal carcinomatcosis development and prolorgs survival in rats. Carcinogenesis, 1999,20(8): 1445
-
4Primorse JN,Bleiberg H,Daniel F, et al. Marimastat in recurrent colortal cancer exploratory evaluation of biological activity by measurement of carcinoembryonic antigen. Br J Cancer, 1999,79 (3-4): 509
-
5Dixon SC,Kruger EA,Bauer KS, et al. Thalidomide up regulates prostate specific antigen secretion from LNCaP cells. Cancer Chemother Pharmacol,1999,43:78
-
6Martinet O, Ermekova V, Qiao JQ, et al. Immunomodulatory gene therapy with interlukin-12 and 4-1BB ligand :long-term remission of liver metastses in a mouse model. J Natl Cancer Inst, 2000, 92(11):931
-
7Bruns CJ, Liu W, Davis DW, et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endithelium in a murine model of colorectal carcinoma liver metastases. Cancer, 2000, 89(3):488
-
8Cao YO, Reilly MS, Marshall B, et al. Expression of angiostatin eDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases J Clim Imaest,1998,101:1055
-
9Sauter BV,Martinet O, Zhang WJ, et al. Adenovirus-mediated gene transfer endostatin in vivo results in high level of transgene expres sion and inhibition of tumor growth and metastases. Proc Natl A cad Sci USA ,2000,97(9) :4802
-
10Li H, Lu H, Griscelli F, et al. Adenovirus-mediated delivery of a uPA/uPAR antagnistns suppresses angiogenesis-depended tumor growth and dissemination in mice. Gene Ther, 1998,5: 1105
共引文献6
-
1刘磊,尚永亮.20世纪“以文为诗”研究述论[J].中州学刊,2004(5):90-94. 被引量:1
-
2明佳,刘旭盛.内皮细胞特异性RTK受体与血管生成[J].第三军医大学学报,2005,27(4):361-363.
-
3范培丽,丁红,朱小东,林希元,张巨波,王文平,孙惠川.实时灰阶超声造影评价肝癌动物模型抗血管生成治疗的研究[J].中华超声影像学杂志,2009,18(8):708-712. 被引量:1
-
4马乐,张荣明,李潇,陈峻江.血管生成素-1对移植颗粒脂肪组织存活率的影响[J].辽宁医学院学报,2010,31(1):42-44. 被引量:2
-
5于蕾.中药对肿瘤组织血管生成的影响[J].哈尔滨商业大学学报(自然科学版),2002,18(4):381-384. 被引量:7
-
6李虎,李小静,高风山,董继英.瘢痕微血管的研究治疗进展[J].整形再造外科杂志,2005(1):42-46. 被引量:9
同被引文献26
-
1宋宝丽.三七噎膈散治疗食管癌咽下困难19例临床观察[J].河北中医,2007,29(9). 被引量:3
-
2李勇,黄伶,张晓丽.噎膈方治疗中晚期食道癌49例疗效观察[J].湖南中医杂志,2004,20(4):1-3. 被引量:7
-
3曾建军,吕仕银,任文烈.活血制癌汤治疗晚期食管癌38例疗效观察[J].现代中西医结合杂志,2004,13(20):2751-2751. 被引量:6
-
4杨学峰,韩兵兵,王润莲.活化开通胶囊联合化疗治疗中晚期食管癌106例[J].中国中西医结合杂志,2004,24(9):855-856. 被引量:9
-
5戴扣城.中西医结合治疗术后反流性食管炎113例[J].中国中西医结合外科杂志,2004,10(6):457-457. 被引量:4
-
6周浣贞,彭惠婷.针灸为主治疗晚期食道癌的临床观察[J].上海针灸杂志,1994,13(6):255-256. 被引量:8
-
7解基良.大承气汤的临床与实验研究进展[J].天津中医,1994,11(1):44-46. 被引量:24
-
8王景祥,梁涛,徐英纳.益气通腑汤在食管贲门癌术后的早期应用[J].中国中西医结合外科杂志,2005,11(3):259-260. 被引量:3
-
9孟金海,孙小芸.中医序贯疗法治疗食管癌17例疗效观察[J].实用中医内科杂志,2006,20(1):62-62. 被引量:3
-
10魏刚.浅谈食管癌的按摩治验[J].按摩与导引,2006,22(7):17-18. 被引量:3
二级引证文献4
-
1刘晶,王庆全,杜业勤.《医学噎膈集成》用药研究[J].河南中医,2010,30(3):303-304. 被引量:3
-
2杜玉.食管癌的中医治疗研究[J].中医临床研究,2010,2(12):111-112. 被引量:3
-
3吕安林.食管癌术后中药辅助治疗42例疗效观察[J].西部中医药,2013,26(8):92-93. 被引量:8
-
4郭燕春,王旬果,陈少平,文鸣磊,郭海生.艾迪注射液联合三维适形放疗治疗中晚期食管癌50例[J].陕西中医,2014,35(5):524-525. 被引量:8
-
1王倩之,罗以,袁志军,朱跃红.尼妥珠单抗联合紫杉醇脂质体、顺铂辅治晚期鼻咽癌的疗效观察[J].临床合理用药杂志,2011,4(17):17-18. 被引量:1
-
2丁政,李建胜.艾迪注射液辅治胃癌根治术后患者38例[J].浙江中西医结合杂志,2009,19(2):96-97. 被引量:7
-
3曹晶杰,宋一雪,蒋潮涌.斑蝥酸钠维生素B_6注射液辅治GP方案化疗NSCLC患者117例[J].中国医学创新,2013,10(19):7-9. 被引量:5
-
4马婧.参芪扶正注射液辅治肺癌合并阻塞性肺炎疗效观察[J].实用中医药杂志,2014,30(1):34-34. 被引量:3
-
5宋莉.氟达拉滨辅治慢性淋巴细胞白血病的疗效分析[J].临床医药文献电子杂志,2016,3(3):443-444.
-
6阮庆峰.^(125)I辅治单发性脑转移瘤临床分析[J].临床合理用药杂志,2011,4(11):101-102.
-
7张建勋,齐金刚,张婷,魏运良.奥曲肽持续静脉泵入辅治恶性肠梗阻对患者血清C-反应蛋白及D-二聚体水平的影响[J].临床合理用药杂志,2015,8(25):89-90.
-
8周寅.中药辅治胃癌术后放化疗1例报道[J].大家健康(学术版),2010(5):33-33.
-
9刘建芳,宇光锋,王久宏,张占山,黄彦林,武乐,冯海涛.妊娠合并子宫肌瘤红色变性患者行剖宫产及剔除肌瘤围术期小剂量肝素辅治对血清Ang-2及VEGF的影响[J].临床合理用药杂志,2015,8(22):100-101. 被引量:5
-
10乐琳琳,沈红燕,黄立萍.健脾补肾方辅治胃癌术后化疗患者临床观察[J].新中医,2015,47(1):195-198. 被引量:10